Seed Funding and Follow-on Investment
Synergis and its parent, Porton Capital, invest in companies at an early stage, but only where they have developed ground-breaking technology platforms which are capable of significant commercial reach. We are therefore very selective, looking for investment opportunities of the highest quality.
We would make a first investment (of up to £1m) probably at the point when much of the technology risk has been overcome, but where market risk and the need to develop a thoroughbred management team still remain. A prototype which we can see and touch always helps, even more so, commercial interest. There are always exceptions and very occasionally we might make a proof of concept investment where the underlying science is breathtaking.
This initial investment can be used for a variety of purposes such as sales and market penetration, productisation, management, IP protection and so on. Following this initial investment, provided good use has been made of it, substantial follow-on investment can be made in the hope and expectation that a significant and valuable business can be created. We support our investments strongly by introducing contacts to help with gaining commercial traction and financial partners.
We are choosy about the sectors we invest in. We focus on defence and security applications, technologies based on physics, diagnostics and other healthcare projects where the regulatory processes are simple, water and energy. We do not invest in drug development or healthcare projects with a complex and long regulatory environment, nor in ICT projects unless they address our preferred sectors.
Porton Capital
Porton Capital is an offshore investment group managing a series of funds created to commercially exploit technologies emerging from the public sector base.
www.portoncapital.com
Note: in compliance with FSA regulations, a username and password are required to access this site. A link to request access is available on the webpage.